German company, Evertz Pharma GmbH, becomes the first in Germany to adopt a strategic Bitcoin reserve model by purchasing an additional 100 BTC in May 2025.
The company began building its Bitcoin treasury in December 2020 with an initial €2 million purchase and has since been regularly allocating corporate profits towards Bitcoin for long-term stability.
Managing Director of Evertz Pharma GmbH, Dominik Evertz, highlights Bitcoin as a scarce and globally tradable asset that complements their reserves and strengthens long-term resilience.
Evertz Pharma distinguishes itself from industry peers and traditional treasury strategies with its latest acquisition of 100 BTC.
The company's Group CFO, Tobias Evertz, expresses their commitment to continuing to invest in Bitcoin to increase holdings sustainably.
Evertz Pharma is privately held and differs from publicly traded Bitcoin adopters like Strategy or Metaplanet.
Bitcoin serves Evertz Pharma as a store of value, hedge against inflation, and diversifies reserves, aiding in capital preservation and without the storage burdens of traditional assets like gold.
The company's treasury strategy exemplifies their dedication to financial sustainability.